Nutex Health (NUTX) Liabilities and Shareholders Equity (2010 - 2026)

Nutex Health has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $957.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 25.65% year-over-year to $957.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 61.6% YoY) and the FY2025 annual result came in at $918.5 million, up 40.16% from the prior year.
• Liabilities and Shareholders Equity improved to $957.3 million in Q1 2026 per NUTX's latest filing, from $918.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $964.5 million in Q3 2025 and troughed at -$10.3 million in Q2 2022.
• A 5-year average of $532.0 million and a median of $436.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity plunged 113.36% in 2022, then soared 4322.36% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $431.8 million in 2022, then retreated by 7.76% to $398.2 million in 2023, then jumped by 64.55% to $655.3 million in 2024, then jumped by 40.16% to $918.5 million in 2025, then climbed by 4.22% to $957.3 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $957.3 million, $918.5 million, and $964.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.